Information  X 
Enter a valid email address

Low & Bonar PLC (LWB)

  Print      Mail a friend       Annual reports

Monday 03 December, 2018

Low & Bonar PLC

Directorate Change

RNS Number : 1350J
Low & Bonar PLC
03 December 2018
 

LEI213800CALFKOEL7N7P10

Low & Bonar PLC

("Low & Bonar" or the "Company")

Appointment of Group Chief Financial Officer

The Company is pleased to announce the appointment of Ian Ashton as Group Chief Financial Officer. Ian will join Low & Bonar and be appointed to the Board as an Executive Director on 10 December 2018.

Ian was previously Chief Financial Officer of Labviva LLC, a US-based technology company. Until December 2017, Ian worked for twenty years at Smith & Nephew plc in various financial roles of increasing seniority in the UK, the US and China. His last role was Chief Financial Officer, Global Operations, and prior to that he served as Chief Financial Officer of their Advanced Surgical Devices Division. Ian qualified as a chartered accountant and began his career at EY.

Further to the announcement of 25 September 2018 and following Ian's appointment, Simon Webb will step down from the Board on 17 December 2018 but will remain an employee until 25 February 2019.

Daniel Dayan, Chairman, commented:

"We are delighted to welcome Ian to the Board and to Low & Bonar's senior management team.  We look forward to his contribution as we develop and implement strategies to deliver operational improvement and profitable growth."

There are no further disclosures required pursuant to paragraphs 9.6.11 to 9.6.13 of the Listing Rules.

For further information, please contact:

Low & Bonar PLC

020 7535 3180

Daniel Dayan, Chairman

Philip de Klerk, Group Chief Executive Officer

 

Instinctif Partners

020 7457 2020

Matthew Smallwood

 

Rosie Driscoll

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAFDAFWSFASEIF

a d v e r t i s e m e n t